Abstract
Protein toxin splicing mediated by split inteins can be used as a strategy for conditional cell ablation. The approach requires artificial fragmentation of a potent protein toxin and tethering each toxin fragment to a split intein fragment. The toxin–intein fragments are, in turn, fused to dimerization domains, such that addition of a dimerizing agent reconstitutes the split intein. These chimeric toxin–intein fusions remain nontoxic until the dimerizer is added, resulting in activation of intein splicing and ligation of toxin fragments to form an active toxin. Considerations for the engineering and implementation of conditional toxin splicing (CTS) systems include: choice of toxin split site, split site (extein) chemistry, and temperature sensitivity. The following method outlines design criteria and implementation notes for CTS using a previously engineered system for splicing a toxin called sarcin, as well as for developing alternative CTS systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Araki K, Araki M, Yamamura K (2006) Negative selection with the Diphtheria toxin A fragment gene improves frequency of Cre-mediated cassette exchange in ES cells. J Biochem 140(6):793–798
Fraser B, DuVal MG, Wang H, Allison WT (2013) Regeneration of cone photoreceptors when cell ablation is primarily restricted to a particular cone subtype. PLoS One 8(1):e55410
Schuldiner M, Itskovitz-Eldor J, Benvenisty N (2003) Selective ablation of human embryonic stem cells expressing a “suicide” gene. Stem Cells 21(3):257–265
Tanoue S, Krishnan P, Krishnan B, Dryer SE, Hardin PE (2004) Circadian clocks in antennal neurons are necessary and sufficient for olfaction rhythms in Drosophila. Curr Biol 14(8):638–649
Cui W, Gusterson B, Clark AJ (1999) Nitroreductase-mediated cell ablation is very rapid and mediated by a p53-independent apoptotic pathway. Gene Ther 6(5):764–770
Denny WA (2003) Prodrugs for gene-directed enzyme-prodrug therapy (suicide gene therapy). J Biomed Biotechnol 2003(1):48–70
Denny WA (2004) Tumor-activated prodrugs--a new approach to cancer therapy. Cancer Invest 22(4):604–619
Kirn D, Niculescu-Duvaz I, Hallden G, Springer CJ (2002) The emerging fields of suicide gene therapy and virotherapy. Trends Mol Med 8(4 Suppl):S68–S73
Malecki M (2012) Frontiers in suicide gene therapy of cancer. J Genet Syndr Gene Ther 2012(3):e114
Ciceri F, Bonini C, Gallo-Stampino C, Bordignon C (2005) Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation. Cytotherapy 7(2):144–149
Qasim W, Gaspar HB, Thrasher AJ (2005) T cell suicide gene therapy to aid haematopoietic stem cell transplantation. Curr Gene Ther 5(1):121–132
Alford SC, O’Sullivan C, Obst J, Christie J, Howard PL (2014) Conditional protein splicing of alpha-sarcin in live cells. Mol Biosyst 10(4):831–837
Eiklid K, Olsnes S, Pihl A (1980) Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. Exp Cell Res 126(2):321–326
Jennings JC, Olson BH, Roga V, Junek AJ, Schuurmans DM (1965) Alpha sarcin, a new antitumor agent. II. Fermentation and antitumor spectrum. Appl Microbiol 13:322–326
Endo Y, Huber PW, Wool IG (1983) The ribonuclease activity of the cytotoxin alpha-sarcin. The characteristics of the enzymatic activity of alpha-sarcin with ribosomes and ribonucleic acids as substrates. J Biol Chem 258(4):2662–2667
Shah NH, Muir TW (2014) Inteins: nature’s gift to protein chemists. Chem Sci 5(1):446–461
Elleuche S, Poggeler S (2010) Inteins, valuable genetic elements in molecular biology and biotechnology. Appl Microbiol Biotechnol 87(2):479–489
Eryilmaz E, Shah NH, Muir TW, Cowburn D (2014) Structural and dynamical features of inteins and implications on protein splicing. J Biol Chem 289(21):14506–14511
Amitai G, Callahan BP, Stanger MJ, Belfort G, Belfort M (2009) Modulation of intein activity by its neighboring extein substrates. Proc Natl Acad Sci U S A 106(27):11005–11010
Xu MQ, Perler FB (1996) The mechanism of protein splicing and its modulation by mutation. EMBO J 15(19):5146–5153
Appleby-Tagoe JH, Thiel IV, Wang Y, Wang Y, Mootz HD, Liu XQ (2011) Highly efficient and more general cis- and trans-splicing inteins through sequential directed evolution. J Biol Chem 286(39):34440–34447
Chong S, Williams KS, Wotkowicz C, Xu MQ (1998) Modulation of protein splicing of the Saccharomyces cerevisiae vacuolar membrane ATPase intein. J Biol Chem 273(17):10567–10577
Binschik J, Zettler J, Mootz HD (2011) Photocontrol of protein activity mediated by the cleavage reaction of a split intein. Angew Chem Int Ed Engl 50(14):3249–3252
Tyszkiewicz AB, Muir TW (2008) Activation of protein splicing with light in yeast. Nat Methods 5(4):303–305
Buskirk AR, Ong YC, Gartner ZJ, Liu DR (2004) Directed evolution of ligand dependence: small-molecule-activated protein splicing. Proc Natl Acad Sci U S A 101(29):10505–10510
Peck SH, Chen I, Liu DR (2011) Directed evolution of a small-molecule-triggered intein with improved splicing properties in mammalian cells. Chem Biol 18(5):619–630
Yuen CM, Rodda SJ, Vokes SA, McMahon AP, Liu DR (2006) Control of transcription factor activity and osteoblast differentiation in mammalian cells using an evolved small-molecule-dependent intein. J Am Chem Soc 128(27):8939–8946
Berrade L, Kwon Y, Camarero JA (2010) Photomodulation of protein trans-splicing through backbone photocaging of the DnaE split intein. Chembiochem 11(10):1368–1372
Wong CC, Traynor D, Basse N, Kay RR, Warren AJ (2011) Defective ribosome assembly in Shwachman-Diamond syndrome. Blood 118(16):4305–4312
Wood DW, Wu W, Belfort G, Derbyshire V, Belfort M (1999) A genetic system yields self-cleaving inteins for bioseparations. Nat Biotechnol 17(9):889–892
Zeidler MP, Tan C, Bellaiche Y, Cherry S, Hader S, Gayko U, Perrimon N (2004) Temperature-sensitive control of protein activity by conditionally splicing inteins. Nat Biotechnol 22(7):871–876
Wu H, Hu Z, Liu XQ (1998) Protein trans-splicing by a split intein encoded in a split DnaE gene of Synechocystis sp. PCC6803. Proc Natl Acad Sci U S A 95(16):9226–9231
Mootz HD, Blum ES, Tyszkiewicz AB, Muir TW (2003) Conditional protein splicing: a new tool to control protein structure and function in vitro and in vivo. J Am Chem Soc 125(35):10561–10569
Mootz HD, Muir TW (2002) Protein splicing triggered by a small molecule. J Am Chem Soc 124(31):9044–9045
Shi J, Muir TW (2005) Development of a tandem protein trans-splicing system based on native and engineered split inteins. J Am Chem Soc 127(17):6198–6206
Zettler J, Schütz V, Mootz HD (2009) The naturally split Npu DnaE intein exhibits an extraordinarily high rate in the protein trans-splicing reaction. FEBS Lett 583(5):909–914
Kanno A, Ozawa T, Umezawa Y (2006) Intein-mediated reporter gene assay for detecting protein-protein interactions in living mammalian cells. Anal Chem 78(2):556–560
Ozawa T, Nogami S, Sato M, Ohya Y, Umezawa Y (2000) A fluorescent indicator for detecting protein-protein interactions in vivo based on protein splicing. Anal Chem 72(21):5151–5157
Ozawa T, Takeuchi TM, Kaihara A, Sato M, Umezawa Y (2001) Protein splicing-based reconstitution of split green fluorescent protein for monitoring protein-protein interactions in bacteria: improved sensitivity and reduced screening time. Anal Chem 73(24): 5866–5874
Ozawa T, Kaihara A, Sato M, Tachihara K, Umezawa Y (2001) Split luciferase as an optical probe for detecting protein-protein interactions in mammalian cells based on protein splicing. Anal Chem 73(11):2516–2521
Sonntag T, Mootz HD (2011) An intein-cassette integration approach used for the generation of a split TEV protease activated by conditional protein splicing. Mol Biosyst 7(6):2031–2039
Narayanan S, Surendranath K, Bora N, Surolia A, Karande AA (2005) Ribosome inactivating proteins and apoptosis. FEBS Lett 579(6):1324–1331
Alford SC, Pearson JD, Carette A, Ingham RJ, Howard PL (2009) Alpha-sarcin catalytic activity is not required for cytotoxicity. BMC Biochem 10:9
Acknowledgements
This work was supported by an NSERC Discovery Grant to PLH. The NMBP and CHis constructs described were the kind gift of Dr. Tom Muir.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Alford, S.C., O’Sullivan, C., Howard, P.L. (2017). Conditional Toxin Splicing Using a Split Intein System. In: Mootz, H. (eds) Split Inteins. Methods in Molecular Biology, vol 1495. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6451-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6451-2_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6449-9
Online ISBN: 978-1-4939-6451-2
eBook Packages: Springer Protocols